Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 53.60
+0.90 (1.71%)
Apr 20, 2026, 9:43 AM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.34 billion as of April 17, 2026. Its market cap has decreased by -27.71% in one year.
Market Cap
6.34B
Enterprise Value
8.37B
Revenue
4.85B
Ranking
n/a
PE Ratio
14.48
Stock Price
53.60
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.34B, an increase of 13.18%. That is a compound annual growth rate of 0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.34B | -11.13% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Handa Pharmaceuticals | 12.15B |
| Foresee Pharmaceuticals | 12.13B |
| Alar Pharmaceuticals | 11.52B |
| Standard Chemical & Pharmaceutical | 11.38B |
| LIWANLI Innovation | 6.11B |
| SCI Pharmtech | 5.80B |
| Orient Pharma | 5.60B |
| Easywell Biomedicals | 5.15B |